Trading Signals: PACB Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Pacific Biosciences of California, Inc. )
| PACB latest price $5.1100 (-1.92%) ($5.0400 - $5.2000) on Thu. Nov. 21, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.81% (three month average) | RSI | 56 | Latest Price | $5.1100(-1.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | PACB advances 1.7% a day on average for past five trading days. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support PACB advance at 0% a week (0% probability) VXX(10%) TLT(9%) BNDX(7%) TIP(7%) VIXM(6%) | Factors Impacting PACB price | PACB will decline at least -1.405% in a week (0% probabilities). VWO(-12%) MCHI(-12%) LIT(-12%) IDRV(-12%) FXI(-12%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.405% (StdDev 2.81%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
5 Day Moving Average | $4.86(5.14%) | 10 Day Moving Average | $4.79(6.68%) | 20 Day Moving Average | $4.8(6.46%) | To recent high | -11.7% | To recent low | 2.2% | Market Cap | $789m | | | | Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. |